Portal de Periódicos da CAPES

Inhibition of Protein Phosphatase-1 by Clavosines A and B

2000; Elsevier BV; Volume: 275; Issue: 6 Linguagem: Inglês

10.1074/jbc.275.6.4192

1083-351X

Tara McCready, Bonnieca Islam, Francis J. Schmitz, Hue Anh Luu, John Dawson, Charles F.B. Holmes,

Protein Tyrosine Phosphatases

Site-directed mutagenesis was used to investigate the mechanism of interaction between the catalytic subunit of human protein phosphatase-1 (PP-1cγ) and members of the calyculin family of toxins. Clavosines A and B are related to calyculins but are glycosylated with a trimethoxy rhamnose group. We provide experimental evidence implicating Tyr-134 as an important residue in PP-1cγ that mediates interactions with the calyculins. Mutation of Tyr-134 to Phe, to prevent hydrogen bond formation, resulted in a slight increase in sensitivity of PP-1cγ to clavosines A and B and calyculin A. In contrast, a Y134A mutant was 10-fold less sensitive to inhibition by all three inhibitors. The greatest effect on inhibition was found by substituting an Asp for Tyr-134 in the phosphatase. Clavosine B inhibited PP-1cγ Y134D with a 310-fold decrease in potency. Clavosine A and calyculin A were also markedly poorer inhibitors of this mutant. These results suggest that a hydrogen bond between Tyr-134 and the calyculins is unlikely to be essential for inhibitor binding to the phosphatase. The clavosines and calyculin A were tested for their ability to inhibit other mutants of PP-1cγ (including Ile-133, Val-223, and Cys-291). Our mutagenesis studies provide an experimental basis for assessing models of calyculin binding found in the literature (Lindvall, M. K., Pihko, P. M., and Koskinen, A. M. (1997) J. Biol. Chem. 272, 23312–23316; Gupta, V., Ogawa, A. K., Du, X., Houk, K. N., and Armstrong, R. W. (1997) J. Med. Chem. 40, 3199–3206; Gauss, C. M., Sheppeck, I. J., Nairn, A. C., and Chamberlain, R. (1997)Bioorg. Med. Chem. 5, 1751–1773). A new model for clavosine and calyculin A binding to PP-1c is presented that is consistent with previous structure-function experiments and which accommodates key structural features of the clavosines, including the novel rhamnose moiety. Site-directed mutagenesis was used to investigate the mechanism of interaction between the catalytic subunit of human protein phosphatase-1 (PP-1cγ) and members of the calyculin family of toxins. Clavosines A and B are related to calyculins but are glycosylated with a trimethoxy rhamnose group. We provide experimental evidence implicating Tyr-134 as an important residue in PP-1cγ that mediates interactions with the calyculins. Mutation of Tyr-134 to Phe, to prevent hydrogen bond formation, resulted in a slight increase in sensitivity of PP-1cγ to clavosines A and B and calyculin A. In contrast, a Y134A mutant was 10-fold less sensitive to inhibition by all three inhibitors. The greatest effect on inhibition was found by substituting an Asp for Tyr-134 in the phosphatase. Clavosine B inhibited PP-1cγ Y134D with a 310-fold decrease in potency. Clavosine A and calyculin A were also markedly poorer inhibitors of this mutant. These results suggest that a hydrogen bond between Tyr-134 and the calyculins is unlikely to be essential for inhibitor binding to the phosphatase. The clavosines and calyculin A were tested for their ability to inhibit other mutants of PP-1cγ (including Ile-133, Val-223, and Cys-291). Our mutagenesis studies provide an experimental basis for assessing models of calyculin binding found in the literature (Lindvall, M. K., Pihko, P. M., and Koskinen, A. M. (1997) J. Biol. Chem. 272, 23312–23316; Gupta, V., Ogawa, A. K., Du, X., Houk, K. N., and Armstrong, R. W. (1997) J. Med. Chem. 40, 3199–3206; Gauss, C. M., Sheppeck, I. J., Nairn, A. C., and Chamberlain, R. (1997)Bioorg. Med. Chem. 5, 1751–1773). A new model for clavosine and calyculin A binding to PP-1c is presented that is consistent with previous structure-function experiments and which accommodates key structural features of the clavosines, including the novel rhamnose moiety. protein phosphatase-1 protein phosphatase-2A inhibitory concentration required to inhibit 50% of enzyme activity Serine/threonine protein phosphatases are highly conserved enzymes, which have been isolated from numerous eukaryotic and prokaryotic organisms (1.Kennelly P.J. Potts M. Front. Biosci. 1999; 4: 372-385Crossref PubMed Google Scholar, 2.Barford D. Das A.K. Egloff M.-P. Annu. Rev. Biophys. Biomol. Struct. 1998; 27: 133-164Crossref PubMed Scopus (571) Google Scholar). Eukaryotic protein phosphatases are inhibited by a structurally diverse array of natural product toxins. These include the polyether okadaic acid from marine dinoflagellates, cyclic peptide microcystins and nodularins from cyanobacteria, and the spiroketal calyculins isolated from marine sponges (3.MacKintosh C. MacKintosh R.W. Trends Biochem. Sci. 1994; 17: 444-447Abstract Full Text PDF Scopus (239) Google Scholar). The first member of the calyculin family of phosphatase inhibitors was identified in 1986 (4.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Fujita S. Furuya T. J. Am. Chem. Soc. 1986; 108: 2780-2781Crossref Scopus (328) Google Scholar). Calyculin A was originally purified from a hydrophobic extract of the marine sponge Discodermia calyx. It was found to be cytotoxic toward P388 and L1210 leukemia cells and to be a strong inhibitor of starfish egg development (4.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Fujita S. Furuya T. J. Am. Chem. Soc. 1986; 108: 2780-2781Crossref Scopus (328) Google Scholar, 5.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Drugs Exp. Clin. Res. 1988; 14: 723-728PubMed Google Scholar). It was subsequently characterized as a powerful inhibitor of the catalytic subunits of type 1 and 2A protein phosphatases, PP-1c1 and PP-2Ac, two of the four major eukaryotic serine/threonine protein phosphatases (6.Ishihara H. Martin B.L. Brautigan D.L. Karaki H. Ozaki H. Kato Y. Fusetani N. Watabe S. Hashimoto K. Uemura D. Hartshorne D.J. Biochem. Biophy. Res. Commun. 1989; 159: 871-877Crossref PubMed Scopus (917) Google Scholar). Calyculin A was also shown to have tumor-promoting activity as potent as that of okadaic acid (7.Suganuma M. Fujiki H. Furuya-Suguri H. Yoshizawa S. Yasumoto S. Kato Y. Fusetani N. Sugimura T. Cancer Res. 1990; 50: 3521-3525PubMed Google Scholar). Many additional calyculins (8.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Koseki K. J. Org. Chem. 1988; 53: 3930-3932Crossref Scopus (129) Google Scholar, 9.Matsunaga S. Fujiki H. Sakata D. Fusetani N. Tetrahedron. 1991; 47: 2999-3006Crossref Scopus (91) Google Scholar, 10.Okada A. Watanabe K. Umeda K. Miyakado M. Agric. Biol. Chem. 1991; 55: 2765-2771Crossref Scopus (18) Google Scholar, 11.Matsunaga S. Wakimoto T. Fusetani N. J. Org. Chem. 1997; 62: 2640-2642Crossref PubMed Scopus (44) Google Scholar, 12.Matsunaga S. Wakimoto T. Fusetani N. Tetrahedron Lett. 1997; 38: 3763-3764Crossref Scopus (35) Google Scholar, 13.Steube K.G. Meyer C. Proksch P. Supriyono A. Sumaryono W. Drexler H.G. Anticancer Res. 1998; 18: 129-137PubMed Google Scholar), and the structurally related calyculinamides (11.Matsunaga S. Wakimoto T. Fusetani N. J. Org. Chem. 1997; 62: 2640-2642Crossref PubMed Scopus (44) Google Scholar, 14.Dumdei E.J. Blunt J.W. Munro M.H.G. Pannell L.K. J. Org. Chem. 1997; 62: 2636-2639Crossref PubMed Scopus (62) Google Scholar), have since been identified. Recently we reported the isolation of two novel glycosylated members of the calyculin family, clavosines A and B from the marine spongeMyriastra clavosa (15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar). Clavosines A and B are potent inhibitors of mammalian PP-1c and PP-2Ac and were found to be more cytotoxic overall than the calyculins and the calyculinamides (14.Dumdei E.J. Blunt J.W. Munro M.H.G. Pannell L.K. J. Org. Chem. 1997; 62: 2636-2639Crossref PubMed Scopus (62) Google Scholar, 15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar) in the National Cancer Institute (NCI) screening panel of tumor cell lines (16.Boyd M.R. Paull K.D. Drug Dev. Res. 1995; 34: 91-109Crossref Scopus (1514) Google Scholar). The polyfunctional structure of clavosines A and B and calyculin A is depicted in linear diagrams (Fig. 1 a) and space filling models (Fig. 1 b). The clavosines (Fig.1) have many structural features in common with the calyculins but differ markedly from them in having a methyl group at C-32 and an unusual trimethoxy rhamnose group at position C-21. Like the calyculinamides, and unlike calyculin A, the clavosines possess an amide at the end of their tetraene tail, as found in the calyculinamides (14.Dumdei E.J. Blunt J.W. Munro M.H.G. Pannell L.K. J. Org. Chem. 1997; 62: 2636-2639Crossref PubMed Scopus (62) Google Scholar). Clavosine A differs from clavosine B in having Z (cis) rather than E (trans) geometry at the C-2=C-3 double bond. Despite the large number of calyculins identified and characterized, we lack a detailed understanding of the molecular mechanisms underlying their interactions with the protein phosphatases. The mode of interaction of calyculin family members with protein phosphatases is controversial (17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar, 18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar, 19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar, 20.Quinn R.J. Taylor C. Suganuma M. Fujiki H. Bioorg. Med. Chem. Lett. 1993; 3: 1029-1034Crossref Scopus (47) Google Scholar). Several models found in the literature are based on the assumption that the phosphate-containing calyculins bind in the same fashion as a phosphorylated substrate or inhibitor. However, a dephosphorylated analog of calyculin A has been found to strongly inhibit PP-1c and PP-2Ac (12.Matsunaga S. Wakimoto T. Fusetani N. Tetrahedron Lett. 1997; 38: 3763-3764Crossref Scopus (35) Google Scholar). This suggests that the phosphate group may not play a major role in the interaction of calyculin A with these protein phosphatases. Recently, the NMR solution structures of calyculin A and dephosphonocalyculin A were determined (21.Volter K.E. Pierens G.K. Quinn R.J. Bioorg. Med. Chem. Lett. 1999; 9: 717-722Crossref PubMed Scopus (7) Google Scholar). The structure of dephosphonocalyculin A was found to be quite similar to that of calyculin A in both methanol and chloroform, implying that the phosphate group is not solely responsible for determining or stabilizing the calyculin structure. To evaluate the roles played by specific amino acid residues in clavosine binding to PP-1c, we have prepared a series of PP-1c mutants. In this study we have characterized the effects of these mutations on the ability of clavosines A and B and calyculin A to inhibit PP-1c. We have exploited this data to develop structural models that describe features important in mediating interactions between the clavosines and PP-1c. Clavosines were purified as described previously (15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar). Calyculin A was obtained from Calbiochem. Other reagents were obtained from Sigma unless otherwise stated. The cDNA encoding PP-1cγ was cloned from a human teratocarcinoma NT2 cDNA library (Stratagene) and subcloned into pBluescriptSK (Stratagene). The PP-1cγ insert was sequenced in its entirety and compared with the published sequence of the γ-isoform (22.Norman S.A. Mott D.M. Mamm. Genome. 1994; 5: 41-45Crossref PubMed Scopus (6) Google Scholar). PP-1cγ mutants were generated using the QuikChange Mutagenesis kit and nativePfu polymerase (Stratagene). All mutant constructs were validated by DNA sequencing. Fragments comprising the wild-type and mutant PP-1cγ cDNA sequences were cloned into the expression vector pCW (generously provided by Dr. Dahlquist, University of Oregon) 17 bases downstream of the promoter and transformed into theEscherichia coli strain DH5α. The recombinant PP-1cγ enzymes (Y134F, Y134A, Y134D, V223A, V223C, I133Y, and C291A) were expressed and purified to homogeneity as described previously (23.Craig M. Luu H.A. McCready T.L. Williams D. Andersen R.J. Holmes C.F.B. Biochem. Cell Biol. 1996; 74: 569-578Crossref PubMed Scopus (135) Google Scholar,24.Dawson J.F. Regulation of Protein Phosphatase-1 by Reversible Phosphorylation and Marine Toxins..in: Ph.D. thesis. University of Alberta, Edmonton, Alberta, Canada1998Google Scholar). Preparations of PP-1cγ mutants had specific activities comparable to wild-type recombinant PP-1cγ. Protein phosphatase-1 inhibition was assayed using 10 μm[32P]phosphorylase a substrate as described previously (25.Holmes C.F.B. Toxicon. 1991; 29: 469-477Crossref PubMed Scopus (86) Google Scholar). Control phosphatase activity was standardized to 15% release of total phosphate from the substrate for each enzyme. Reactions were initiated by the addition of substrate, and assays were performed in duplicate. Reactions involving the clavosines were performed under low light conditions to prevent photochemical isomerization of the terminal tetraene unit. Structures and binding models were generated on a Silicon Graphics Indigo 2T. L. McCready and C. F. B. Holmes, manuscript in preparation. Impact 10000 workstation using Insight II software (ver. 95.0.4) developed by Biosym/MSI Technologies Inc. of San Diego. Docking simulations were performed using the extensible subset forcefield with the fixed docking method of Insight II. Energy minimization was performed using the Discover 3 (ver. 3.0) module of Insight II with the extensible subset forcefield. The structure of Calyculin A (4.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Fujita S. Furuya T. J. Am. Chem. Soc. 1986; 108: 2780-2781Crossref Scopus (328) Google Scholar) was obtained from the Cambridge Crystallographic Data Center (code DUPSUW). In contrast to previous work published in collaboration with our laboratory (26.Bagu J.R. Sykes B.D. Craig M.M. Holmes C.F.B. J. Biol. Chem. 1997; 272: 5087-5097Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar), this calyculin A structure was inverted to obtain the correct, natural enantiomer (27.Matsunaga S. Fusetani N. Tetrahedron Lett. 1991; 32: 5605-5606Crossref Scopus (55) Google Scholar). Although the absolute configurations of the clavosines have not been determined, they are assumed to be the same as those established for calyculins (15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar). Charges were adjusted to −2 for the phosphate group, but the dimethylamine was maintained in the free base form (27.Matsunaga S. Fusetani N. Tetrahedron Lett. 1991; 32: 5605-5606Crossref Scopus (55) Google Scholar). The x-ray crystallographic coordinates of PP-1cα bound to microcystin-LR (28.Goldberg J. Huang H.B. Kwon Y.G. Greengard P. Nairn A.C. Kuriyan J. Nature. 1995; 376: 745-753Crossref PubMed Scopus (755) Google Scholar) were obtained from the Protein Data Bank (PDB code1FJM). Chain B of the structure was deleted, as was microcystin-LR and all water molecules. To complete the structure, amino acid side chains only partially detected by crystallographic methods were added, as were hydrogens appropriate for pH 7. Docking was carried out with half of the amino acid residues of PP-1c (those comprising the active site “face” of the protein) designated as the ligand-binding subset. We employed Metropolis docking at a temperature of 300 K with 200 minimization steps between structure evaluations. Several starting positions were investigated for each inhibitor. The lowest energy structures generated were examined and subjected to a more rigorous energy minimization using Discover 3. Promising structures were used as the starting position for a second round of docking. During minimization of the docked models, subsets of the protein were defined so that amino acid residues within 10 Å of the inhibitor were allowed to be flexible, while the rest of the protein was held fixed. The PP-1c-inhibitor complex was soaked with water molecules at a thickness of 5 Å and minimized to a convergence of 0.05 kcal/mol/Å using the steepest descent and conjugate gradient algorithms. Clavosine A inhibited PP-1cγ and PP-2Ac (Fig. 2, IC50 = 0.5 and 0.6 nm, respectively) with virtually identical potency to calyculin A (Fig.2, IC50 = 0.7 and 0.5 nm, respectively). These data presumably reflect the similarities in orientation and overall structure of calyculin A and clavosine A. Clavosine B inhibited recombinant PP-1cγ with decreased potency (IC50 = 13 nm) but was almost as effective a PP-2Ac inhibitor (IC50 = 1.2 nm) as clavosine A or calyculin A. Whereas the C-2/C-3 E geometry of clavosine B resulted in a >25-fold increase in IC50 for this compound against PP-1cγ, this increase could not be attributed to the presence of a bulky rhamnose group, because clavosine A was as potent a protein phosphatase inhibitor as calyculin A. To further understand the mechanisms underlying the inhibition of PP-1cγ by the clavosines, we examined the inhibitory effects of these toxins on a number of mutants of PP-1cγ. The crystal structure of microcystin-LR bound to PP-1c (28.Goldberg J. Huang H.B. Kwon Y.G. Greengard P. Nairn A.C. Kuriyan J. Nature. 1995; 376: 745-753Crossref PubMed Scopus (755) Google Scholar) and molecular modeling studies of microcystins and okadaic acid bound to PP-1 (17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar, 18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar) suggest that Tyr-134 may be important for interaction with calyculins and clavosines. Three Tyr-134 PP-1cγ mutants allowed us to thoroughly investigate the role this amino acid residue plays in inhibition of the phosphorylase aphosphatase activity of PP-1cγ by the clavosines and calyculin A (Fig. 3). The first mutant was PP-1cγ Y134F, in which the potential for hydrogen bonding with bound toxins was abolished with the tyrosine to phenylalanine mutation. The second mutant was Y134A, in which both the hydroxyl and hydrophobic aromatic ring were replaced by an alanine sidechain. The third mutant was Y134D, in which an aspartic acid residue was inserted to introduce a negative charge in this region. PP-1cγ Y134F was inhibited by clavosine A, clavosine B, and calyculin A slightly more strongly (IC50 = 0.2, 9.5, and 0.3 nm, respectively) than wild-type recombinant PP-1cγ (IC50 = 0.5, 13, and 0.7 nm, respectively). In contrast, Y134A was inhibited less potently by clavosine A, clavosine B, and calyculin A (IC50 = 5.5, 145, and 2 nm, respectively). Y134D was significantly resistant to inhibition by clavosine A, clavosine B, and calyculin A (IC50 = 93, 4050, and 125 nm, respectively). Calcineurin (protein phosphatase-2B) is a protein phosphatase homologous to PP-1 but strongly resistant to inhibition by calyculin A (3.MacKintosh C. MacKintosh R.W. Trends Biochem. Sci. 1994; 17: 444-447Abstract Full Text PDF Scopus (239) Google Scholar). In calcineurin the residue corresponding to Val-223 in PP-1cγ is a cysteine (Cys-256). It was therefore of interest to mutate PP-1cγ Val-223 to Ala and Cys in order to determine whether this residue may be involved in clavosine inhibition of PP-1cγ (Fig.4). PP-1cγ V223C was inhibited by clavosine A, clavosine B, and calyculin A with similar potency (IC50 = 0.6, 22, and 0.9 nm, respectively) to wild-type PP-1cγ (IC50 = 0.5, 13, and 0.7 nm, respectively). Surprisingly, V223A was more strongly inhibited by clavosine A, clavosine B, and calyculin A (IC50 = <0.1, 1, and 0.1 nm, respectively) than the wild-type enzyme. These experiments suggest that replacing the more bulky side chain of valine with alanine may allow the calyculins, especially clavosine B, to interact more closely with PP-1c in this region, thus reducing the IC50 values for each inhibitor. The clavosines and calyculin A were additionally tested for inhibitory activity against other PP-1cγ mutant enzymes. The results from these studies are depicted in Table I. Despite its proximity in sequence number to Tyr-134, mutation of Ile-133 to Tyr resulted in no significant change in response to the clavosines and calyculin A. We also examined the effect of replacing Cys-291 with Ala on toxin inhibition. This residue was chosen for our mutagenesis studies because it has been proposed (29.Egloff M.P. Johnson D.F. Moorhead G. Cohen P.T. Cohen P. Barford D. EMBO J. 1997; 16: 1876-1887Crossref PubMed Scopus (537) Google Scholar) to be part of an essential binding motif that is involved in the interaction of PP-1c with inhibitor-1, a phosphoprotein inhibitor specific to PP-1c. 2T. L. McCready and C. F. B. Holmes, manuscript in preparation. PP-1cγ C291A was inhibited by the clavosines and calyculin A with almost identical potency to wild-type recombinant PP-1cγ.Table IInhibition of mutant PP-1cγ enzymes by clavosine A, B, and calyculin APP-1cγCalyculin AClavosine AClavosine BIC50IC50IC50nmnmnmWild-type0.7 (± 0.28)0.5 (± 0.1)13 (± 0.58)Y134F0.3 (± 0.06)0.2 (± 0.06)9.5 (± 3.5)Y134A7.0 (± 2.1)5.5 (± 0.5)145 (± 9.4)Y134D125 (± 11)93 (± 6.7)4050 (± 44)V223A0.1 (± 0.05)<0.11.0 (± 0.4)V223C0.9 (± 0.26)0.6 (± 0.10)22 (± 3.6)I133Y1.2 (± 0.40)0.6 (± 0.15)15 (± 3.9)C291A1.5 (± 0.56)0.8 (± 0.25)17 (± 2.5)PP-1c mutants were generated as described under “Experimental Procedures.” PP-1cγ activity was measured using 10 μm[32P]phosphorylase a as a substrate. Each value (± S.D.) represents the average of 3–5 independent experiments with a full range of inhibitor concentrations. Open table in a new tab PP-1c mutants were generated as described under “Experimental Procedures.” PP-1cγ activity was measured using 10 μm[32P]phosphorylase a as a substrate. Each value (± S.D.) represents the average of 3–5 independent experiments with a full range of inhibitor concentrations. We carried out modeling studies on the interaction between the clavosines and PP-1c to address three aspects of calyculin and clavosine structures: the position of the phosphate group with respect to the phosphatase, correlation of IC50 data with the orientation of the amide/nitrile portion of the tetraene tail, and accommodation of the rhamnose moiety in the PP-1c-clavosine complex. Using the experimental data generated in our mutagenesis studies and exploiting PP-1c structure-function information found in the literature (9.Matsunaga S. Fujiki H. Sakata D. Fusetani N. Tetrahedron. 1991; 47: 2999-3006Crossref Scopus (91) Google Scholar, 11.Matsunaga S. Wakimoto T. Fusetani N. J. Org. Chem. 1997; 62: 2640-2642Crossref PubMed Scopus (44) Google Scholar, 12.Matsunaga S. Wakimoto T. Fusetani N. Tetrahedron Lett. 1997; 38: 3763-3764Crossref Scopus (35) Google Scholar, 15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar, 30.Huang H.B. Horiuchi A. Goldberg J. Greengard P. Nairn A.C. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3530-3535Crossref PubMed Scopus (76) Google Scholar, 31.Zhang L. Zhang Z. Long F. Lee E.Y. Biochemistry. 1996; 35: 1606-1611Crossref PubMed Scopus (68) Google Scholar), we generated hypothetical models for clavosine binding to PP-1c. Our models of clavosine A, clavosine B, and calyculin A binding are depicted in Fig.5. Use of the extensible subset forcefield allowed us to perform all docking and minimization steps with manganese ions present at the active site of PP-1c. We were therefore able to initiate docking without fixing any portion of the clavosines in the active site. In this way, our modeling studies were performed without initial bias. It was necessary to use coordinates of the α-isoform of PP-1c (28.Goldberg J. Huang H.B. Kwon Y.G. Greengard P. Nairn A.C. Kuriyan J. Nature. 1995; 376: 745-753Crossref PubMed Scopus (755) Google Scholar) for the modeling studies as coordinates for the γ-isoform were not available. The α- and γ-isoforms of PP-1c are nearly identical, with primary sequence differences located almost exclusively in the first 5 residues of the amino terminus and the last 29 residues of the carboxyl terminus. The inhibitor/phosphatase structures generated in our modeling studies were similar for each inhibitor. Tyrosine 134, one of the PP-1c residues mutated in this study, is predicted to lie within 3 Å of the dimethylamine group in all of the inhibitor models, in close proximity with the amine (Fig. 1 a) in the clavosine A and calyculin A structures and the C-35 hydroxyl in clavosine B. Val-223 is within 3.5 Å of each inhibitor, residing closer to clavosine B (<3 Å) than the other two compounds. From the model, the phosphate group in clavosine A and calyculin A is predicted to form a hydrogen bond with Arg-96 in PP-1c. All three models suggest a contact between the C-13 hydroxyl of the calyculin or clavosine and Arg-221 in PP-1c, with the clavosine B predicted to lie the closest to this amino acid. In both clavosine models, the C-1 amide carbonyl group is predicted to form a contact with Lys-211, whereas the amide NH2 group in clavosine B may also interact with Asp-210. Asn-124 appears to reside within 3 Å of the C-33 carbonyl of each inhibitor. Additional residues in PP-1c predicted to reside within 4 Å of the inhibitor in every model include: His-66, Asp-92, His-125, Ile-130, Arg-132, Trp-206, Asp-208, Pro-209, Asp-210, Asn-219, Asp-220, Thr-226, His-248, Gln-249, Val-250, and Tyr-272. In addition, the manganese ions in the active site of the enzyme are within 4 Å of the inhibitors in all of the models. Fig.6 displays residues in PP-1c mutated in this study, relative to the active site of the phosphatase. In addition, some of the amino acids shown to be involved in calyculin A inhibition of PP-1c by other researchers (30.Huang H.B. Horiuchi A. Goldberg J. Greengard P. Nairn A.C. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3530-3535Crossref PubMed Scopus (76) Google Scholar, 31.Zhang L. Zhang Z. Long F. Lee E.Y. Biochemistry. 1996; 35: 1606-1611Crossref PubMed Scopus (68) Google Scholar) are highlighted. Asp-210 and Lys-211, two residues proposed to be involved in clavosine and calyculin binding by computer modeling studies contained in this paper, are also indicated. In this study clavosines A and B have been identified as powerful protein phosphatase inhibitors, comparable to the other members of the calyculin family of natural product toxins. We have also shown that the Tyr-134 residue of PP-1cγ is an important mediator of inhibition by these compounds. Mutation of Tyr-134 to Phe resulted in a slight decrease in IC50 for all three inhibitors, possibly indicative of an increased hydrophobic interaction with the Phe side chain in the absence of a hydroxyl group. Substitution of the aromatic side chain in this position for alanine significantly increased the IC50values of clavosines A, B, and calyculin A. The most dramatic effect on clavosine inhibition of PP-1c was found by substituting Asp in place of Tyr-134. Clavosine B inhibited PP-1cγ Y134D with an approximately 310-fold decrease in potency compared with its inhibition of wild-type enzyme. Clavosine A and calyculin A were also markedly poorer inhibitors of the Y134D mutant (200- and 175-fold worse, respectively). These results clearly show that the presence of a negative charge at residue 134 in PP-1c is unfavorable for calyculin or clavosine inhibition. A recent computer modeling paper (18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar) has suggested that Tyr-134 may be involved in calyculin binding to PP-1c. Our mutagenesis data is the first experimental evidence to confirm the importance of this residue for inhibitor binding. The only known three-dimensional structure of an inhibitor bound to PP-1c is the x-ray structure of a microcystin-LR-PP-1cα complex determined by Goldberg et al. (28.Goldberg J. Huang H.B. Kwon Y.G. Greengard P. Nairn A.C. Kuriyan J. Nature. 1995; 376: 745-753Crossref PubMed Scopus (755) Google Scholar). One of the three areas of interaction between microcystin-LR and the phosphatase involved a possible hydrogen bond between the d-erythro-β-methyl aspartic acid carboxylate group and Tyr-134 of PP-1c. Therefore, mutagenesis of Tyr-134 serves as an important first starting point to test proposed models for binding of other toxins to PP-1c. In fact, the PP-1c Y134F mutant is actually more susceptible to inhibition by clavosine A/B and calyculin A than wild-type enzyme, thus arguing against the importance of hydrogen bonding between this residue and the calyculins. In addition to the present work, there are three recent docking/modeling papers that address calyculin A binding to PP-1c: Gauss et al. (17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar), Gupta et al. (18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar), and Lindvall et al. (19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar). The Gupta et al. (18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar) publication proposes a direct role for Tyr-134 in calyculin binding to PP-1c. Their modeling studies propose hydrogen bonding between 1) the C-17 phosphate and C-35 hydroxyl of calyculin A with Arg-96 and 2) the C-34 hydroxyl and C-37 methoxy group of calyculin A with Tyr-134. We chose to test whether Tyr-134 was likely to make any hydrogen bond contact with the calyculins by mutating this residue to Phe. In view of the data presented here, it is possible that this model is incorrect with respect to hydrogen bond formation between calyculin A and PP-1c. The calyculin binding models of Gauss et al. (17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar) and Lindvall et al. (19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar) make no direct mention of the involvement of Tyr-134 in calyculin A binding. In contrast, our mutagenesis experiments suggest a role for the bulky aromatic ring of the Tyr-134 sidechain in phosphatase inhibition by the calyculins. The models of calyculin and clavosine binding presented in Fig. 5 allow for close interaction with Tyr-134 but not Ile-133 (see Fig. 6). This is an important point, because in this study we showed that mutation of Ile-133 to Tyr did not affect the potency of PP-1c inhibition by the clavosines (Table I). It has been widely suggested in the literature (recently in Refs. 17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar,18.Gupta V. Ogawa A.K. Du X. Houk K.N. Armstrong R.W. J. Med. Chem. 1997; 40: 3199-3206Crossref PubMed Scopus (76) Google Scholar, and 30.Huang H.B. Horiuchi A. Goldberg J. Greengard P. Nairn A.C. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3530-3535Crossref PubMed Scopus (76) Google Scholar) that many of the natural product inhibitors of PP-1c are similar enough in structure and chemical composition to create a common set of contacts with residues in the active site of the enzyme. Our proposed models of clavosine binding to PP-1c are consistent with this idea. Other recent mutagenesis studies have determined that Tyr-272 and Arg-96 mutant PP-1c enzymes exhibit decreased sensitivity to calyculin A (30.Huang H.B. Horiuchi A. Goldberg J. Greengard P. Nairn A.C. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3530-3535Crossref PubMed Scopus (76) Google Scholar, 31.Zhang L. Zhang Z. Long F. Lee E.Y. Biochemistry. 1996; 35: 1606-1611Crossref PubMed Scopus (68) Google Scholar) (Fig. 6). The mutants Asn-124, Asp-208, Arg-221, and His-248 also displayed resistance to this inhibitor (30.Huang H.B. Horiuchi A. Goldberg J. Greengard P. Nairn A.C. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3530-3535Crossref PubMed Scopus (76) Google Scholar, 31.Zhang L. Zhang Z. Long F. Lee E.Y. Biochemistry. 1996; 35: 1606-1611Crossref PubMed Scopus (68) Google Scholar). In our models, all of these residues are found to be within 4 Å of clavosines A, B, and calyculin A. The clavosine structures generated in our modeling experiments maintain the compact nature of the (inverted) calyculin A crystal structure (4.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Fujita S. Furuya T. J. Am. Chem. Soc. 1986; 108: 2780-2781Crossref Scopus (328) Google Scholar) and NMR solution structure (21.Volter K.E. Pierens G.K. Quinn R.J. Bioorg. Med. Chem. Lett. 1999; 9: 717-722Crossref PubMed Scopus (7) Google Scholar), forming a “wedge” shape that fits into the active site of the phosphatase (Fig. 5). Our models are based on the premise that calyculins bind in a compact manner, as opposed to the extended calyculin model structures found in the literature (19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar). Recently, the NMR solution structures of calyculin A and dephosphonocalyculin A in organic solvents were determined (21.Volter K.E. Pierens G.K. Quinn R.J. Bioorg. Med. Chem. Lett. 1999; 9: 717-722Crossref PubMed Scopus (7) Google Scholar). In chloroform, the solution structure of calyculin A is very similar to the reported crystal structure (4.Kato Y. Fusetani N. Matsunaga S. Hashimoto K. Fujita S. Furuya T. J. Am. Chem. Soc. 1986; 108: 2780-2781Crossref Scopus (328) Google Scholar). Clavosine B inhibits recombinant PP-1cγ with an IC50value 26-fold greater than that observed for clavosine A. This increase in IC50 is in agreement with the model shown in Fig.5 b. Our model suggests that the C-2/C-3 geometry of clavosine B forces the amide portion of the inhibitor toward the phosphatase structure, which results in a slight “downward” shift away from the active site of PP-1c. In both clavosine models, the C-1 amide carbonyl appears to form a contact with Lys-211 of PP-1c. However, the orientation of clavosine B may allow formation of an additional contact between Asp-210 and the amide NH2 group of the inhibitor, perhaps explaining the shift in the modeled complex. This movement away from the active site of the phosphatase may account for the reduction in effectiveness of clavosine B as an inhibitor of the recombinant enzyme. Our models of clavosine binding to PP-1c orient the phosphate group of each of the clavosines and calyculin A such that it interacts closely with Arg-96 of the phosphatase. However, given the strong inhibitory activity of dephospho-calyculin A toward PP-1c (12.Matsunaga S. Wakimoto T. Fusetani N. Tetrahedron Lett. 1997; 38: 3763-3764Crossref Scopus (35) Google Scholar), it is unlikely that this interaction forms the sole driving force for inhibition of the phosphatase. We found that calyculin A does not appear to depend solely on the phosphate group for maintaining its internal structure or its interaction with PP-1c, as dephospho-calyculin A docked similarly to the models in Fig. 5, despite loss of contact with Arg-96 (data not shown). During docking and energy minimization, the dephosphonoanalog exhibited internal structural changes consistent with previously determined experimental and structural observations (12.Matsunaga S. Wakimoto T. Fusetani N. Tetrahedron Lett. 1997; 38: 3763-3764Crossref Scopus (35) Google Scholar). It will be interesting to compare our model to the recently published NMR structure of the dephosphonoanalog when the coordinates become available (21.Volter K.E. Pierens G.K. Quinn R.J. Bioorg. Med. Chem. Lett. 1999; 9: 717-722Crossref PubMed Scopus (7) Google Scholar). The calyculin phosphate group is an important part of an “extended” model of calyculin binding to PP-1c that has been presented in the literature, which proposes that the phosphate-containing calyculin is a mimic of the phosphorylated PP-1c inhibitor protein inhibitor-1 (or the related protein DARPP-32). Several models of calyculin binding (17.Gauss C.M. Sheppeck I.J. Nairn A.C. Chamberlain R. Bioorg. Med. Chem. 1997; 5: 1751-1773Crossref PubMed Scopus (51) Google Scholar, 19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar) appear to be based, at least in part, upon models of phospho-DARPP-32 or inhibitor-1 interactions with PP-1c. Our computer simulations of clavosine binding suggest that the calyculin family of inhibitors do not bind as linear, phospho-peptidomimetics as has been previously proposed (19.Lindvall M.K. Pihko P.M. Koskinen A.M.P. J. Biol. Chem. 1997; 272: 23312-23316Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar). In our models the trimethoxy rhamnose group found in the clavosine structures is positioned so that it cannot interfere with toxin/protein binding. This is in accordance with data from our PP-1c inhibition assays (Fig. 2), which indicate that calyculin A and clavosine A inhibit PP-1cγ with similar potencies. In both clavosine models the rhamnose resides close to Glu-275 and Phe-276 in PP-1c but is clearly oriented away from the enzyme. The average cytotoxicity of the clavosines was higher than that of calyculin A in the NCI cell culture screens (15.Fu X. Schmitz F.J. Kelly-Borges M. McCready T.L. Holmes C.F.B. J. Org. Chem. 1998; 63: 7957-7963Crossref Scopus (39) Google Scholar). This implies a targeting role for the rhamnose group. Lectins are a group of proteins that recognize specific carbohydrates and are involved in host-pathogen interactions, targeting of proteins within cells, and cell-cell interactions (32.Rini J.M. Annu. Rev. Biophys. Biomol. Struct. 1995; 24: 551-577Crossref PubMed Scopus (430) Google Scholar, 33.Weis W.I. Drickamer K. Annu. Rev. Biochem. 1996; 65: 441-473Crossref PubMed Scopus (1010) Google Scholar, 34.Elgavish S. Shaanan B. Trends Biochem. Sci. 1997; 22: 462-467Abstract Full Text PDF PubMed Scopus (219) Google Scholar). It is possible that a rhamnose-specific lectin could be involved in clavosine binding and uptake by a particular cell type or in an intracellular targeting mechanism. Rhamnose-specific lectins have been predominantly identified in fish eggs (35.Hosono M. Kawauchi H. Nitta K. Takayanagi Y. Shiokawa H. Mineki R. Murayama K. Biol. Pharm. Bull. 1993; 16: 239-243Crossref PubMed Scopus (32) Google Scholar, 36.Gabius H.J. Cancer Invest. 1987; 5: 39-46Crossref PubMed Scopus (101) Google Scholar, 37.Tateno H. Saneyoshi A. Ogawa T. Muramoto K. Kamiya H. Saneyoshi M. J. Biol. Chem. 1998; 273: 19190-19197Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Perhaps the clavosines discourage predation of marine sponges and/or associated microorganism(s) that produce the compounds; species of fish with rhamnose-specific lectins could be harmed if the clavosines were ingested. Interestingly, some cancer cell types may have receptors that recognize a rhamnose or rhamnose-like residue. Binding of solasodine glycosides (rhamnose-containing sugars) to tumor cells is thought to occur via a rhamnose moiety. These sugars selectively destroy tumor cellsin vivo (38.Cham B.E. Daunter B. Cancer Lett. 1990; 55: 221-225Crossref PubMed Scopus (65) Google Scholar). In conclusion, there is a great need for further NMR or x-ray crystallographic work in this area. Determination of the structure of the clavosines or calyculin A in complex with PP-1c would address many of the controversial questions regarding the specific mode of interaction between the calyculins and type 1 protein phosphatase. Investigations along these lines are currently underway in our laboratory. Further characterization of the anti-tumor activity of the calyculin family members is also needed if we are to take full advantage of this cell permeable class of phosphatase inhibitors. We thank Dr. Marcia Craig for many helpful conversations and Torin Huzil for his assistance with the computer modeling studies. We also thank Dr. Mike Ellison for access to the Silicon Graphics Workstation.